/UHS
UHS Stock - Universal Health Services, Inc.
Healthcare|Medical - Care FacilitiesNYSE
$227.46+1.21%
+$2.72 (+1.21%) • Dec 19
69
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.80
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).71
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.69
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.6%upside
Target: $251.57
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for UHS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$225.19 – $229.73
TARGET (TP)$251.55
STOP LOSS$209.26
RISK/REWARD1:1.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.27
52W High$246.33
52W Low$152.33
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $15.83B | $14.28B | $13.40B | $12.64B | $11.56B |
| Gross Profit | $14.24B | $12.75B | $11.93B | $11.21B | $10.27B |
| Gross Margin | 90.0% | 89.3% | 89.0% | 88.7% | 88.9% |
| Operating Income | $1.68B | $1.18B | $1.00B | $1.36B | $1.36B |
| Net Income | $1.14B | $717.79M | $675.61M | $991.59M | $943.95M |
| Net Margin | 7.2% | 5.0% | 5.0% | 7.8% | 8.2% |
| EPS | $17.16 | $10.35 | $9.23 | $11.99 | $11.06 |
Company Overview
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
7
29%
Hold / Neutral
15
63%
Sell / Underperform
2
8%
Analyst Consensus🔴 Bearish
7 Bullish17 Neutral/Bearish
Price Targets
$189
Average Target
↓ 16.7% Downside
Now
$90
Low
$189
Average
$283
High
Based on 27 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 3rd 2025 | Raymond James | Upgrade | Outperform | $270 |
| October 14th 2025 | Goldman | Resumed | Neutral | $219 |
| July 16th 2025 | BofA Securities | Downgrade | Underperform | $185 |
| April 15th 2025 | Robert W. Baird | Downgrade | Neutral | $224 |
| March 26th 2025 | Morgan Stanley | Initiation | Equal Weight | $200 |
| February 3rd 2025 | Cantor Fitzgerald | Upgrade | Overweight | - |
| December 17th 2024 | JP Morgan | Resumed | Neutral | $226 |
| December 16th 2024 | Goldman | Downgrade | Neutral | $198← $228 |
| November 6th 2024 | BofA Securities | Resumed | Neutral | $223 |
| October 16th 2024 | TD Cowen | Upgrade | Buy | $283← $220 |
| October 11th 2024 | KeyBanc Capital Markets | Initiation | Sector Weight | - |
| July 26th 2024 | Cantor Fitzgerald | Upgrade | Neutral | $219← $162 |
| July 26th 2024 | Barclays | Upgrade | Overweight | $256 |
| June 26th 2024 | Robert W. Baird | Upgrade | Outperform | $236← $198 |
| May 30th 2024 | Robert W. Baird | Initiation | Neutral | $198 |
Earnings History & Surprises
UHSBeat Rate
83%
Last 18 quarters
Avg Surprise
+9.1%
EPS vs Estimate
Beats / Misses
15/3
Last 12 quarters
Latest EPS
$5.69
Q4 2025
EPS Surprise History
Q1 24
+8.7%
$3.13vs$2.88
Q2 24
+17.5%
$3.70vs$3.15
Q3 24
+31.4%
$4.31vs$3.28
Q4 24
+1.6%
$3.71vs$3.65
Q1 25
+16.9%
$4.92vs$4.21
Q2 25
+11.3%
$4.84vs$4.35
Q3 25
+8.7%
$5.35vs$4.92
Q4 25
+22.1%
$5.69vs$4.66
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q1 2026 | Feb 25, 2026 | $5.87 | — | — | — |
Q4 2025 | Oct 27, 2025 | $4.66 | $5.69 | +22.1% | ✓ BEAT |
Q3 2025 | Jul 28, 2025 | $4.92 | $5.35 | +8.7% | ✓ BEAT |
Q2 2025 | Apr 28, 2025 | $4.35 | $4.84 | +11.3% | ✓ BEAT |
Q1 2025 | Feb 26, 2025 | $4.21 | $4.92 | +16.9% | ✓ BEAT |
Q4 2024 | Oct 24, 2024 | $3.65 | $3.71 | +1.6% | ✓ BEAT |
Q3 2024 | Jul 24, 2024 | $3.28 | $4.31 | +31.4% | ✓ BEAT |
Q2 2024 | Apr 24, 2024 | $3.15 | $3.70 | +17.5% | ✓ BEAT |
Q1 2024 | Feb 27, 2024 | $2.88 | $3.13 | +8.7% | ✓ BEAT |
Q4 2023 | Oct 25, 2023 | $2.36 | $2.55 | +8.1% | ✓ BEAT |
Q3 2023 | Jul 25, 2023 | $2.43 | $2.53 | +4.1% | ✓ BEAT |
Q2 2023 | Apr 25, 2023 | $2.19 | $2.34 | +6.8% | ✓ BEAT |
Q1 2023 | Feb 27, 2023 | $2.96 | $3.02 | +2.0% | ✓ BEAT |
Q4 2022 | Oct 25, 2022 | $2.43 | $2.54 | +4.5% | ✓ BEAT |
Q3 2022 | Jul 25, 2022 | $2.35 | $2.20 | -6.4% | ✗ MISS |
Q2 2022 | Apr 25, 2022 | $2.46 | $2.15 | -12.6% | ✗ MISS |
Q1 2022 | Feb 24, 2022 | $2.87 | $2.95 | +2.8% | ✓ BEAT |
Q4 2021 | Oct 25, 2021 | $2.75 | $2.67 | -2.9% | ✗ MISS |
Q3 2021 | Jul 26, 2021 | $2.70 | $3.76 | +39.3% | ✓ BEAT |
Latest News
Guggenheim Maintains Buy on Universal Health Services, Raises Price Target to $274
📈 PositiveBenzinga•Dec 2, 2025, 12:37 PM
Wells Fargo Maintains Overweight on Universal Health Services, Raises Price Target to $259
📈 PositiveBenzinga•Nov 13, 2025, 03:37 PM
RBC Capital Maintains Sector Performer on Universal Health Services, Raises Price Target to $231
📈 PositiveBenzinga•Oct 30, 2025, 03:44 PM
UBS Maintains Buy on Universal Health Services, Raises Price Target to $302
📈 PositiveBenzinga•Oct 29, 2025, 06:02 PM•Also:
Cantor Fitzgerald Maintains Neutral on Universal Health Services, Raises Price Target to $250
➖ NeutralBenzinga•Oct 29, 2025, 02:06 PM
Guggenheim Maintains Buy on Universal Health Services, Raises Price Target to $253
📈 PositiveBenzinga•Oct 29, 2025, 12:52 PM
Barclays Maintains Overweight on Universal Health Services, Raises Price Target to $263
📈 PositiveBenzinga•Oct 28, 2025, 01:26 PM•Also:
Universal Health Services shares are trading higher after the company reported better-than-expected Q3 financial results and raised FY2025 EPS and sales guidance.
📈 PositiveBenzinga•Oct 27, 2025, 08:43 PM
Universal Health Realty Q3 EPS $0.29, Same YoY, Sales $25.302M Beat $24.900M Estimate
➖ NeutralBenzinga•Oct 27, 2025, 08:26 PM
Universal Health Services Raises FY2025 Adj EPS Guidance from $20.00-$21.00 to $21.50-$22.10 vs $20.63 Est; Raises FY2025 Sales Guidance from $17.096B-$17.312B to $17.306B-$17.445B vs $17.213B Est
📈 PositiveBenzinga•Oct 27, 2025, 08:18 PM
Universal Health Servs Q3 Adj. EPS $5.69 Beats $4.79 Estimate, Sales $4.495B Beat $4.345B Estimate
📈 PositiveBenzinga•Oct 27, 2025, 08:17 PM
Goldman Sachs Assumes Universal Health Services at Neutral, Announces Price Target of $219
➖ NeutralBenzinga•Oct 14, 2025, 12:48 PM•Also:
Wells Fargo Maintains Overweight on Universal Health Services, Raises Price Target to $249
📈 PositiveBenzinga•Oct 7, 2025, 01:48 PM
Cantor Fitzgerald Reiterates Neutral on Universal Health Services, Maintains $227 Price Target
➖ NeutralBenzinga•Oct 7, 2025, 01:24 PM
Universal Health Services Says Jury Awards $500M Punitive Damages Against UHS Of Delaware In Nevada Lawsuit; Co Expects Punitive Damages To Reduce To $14M In Nevada Lawsuit
📉 NegativeBenzinga•Sep 29, 2025, 01:33 PM
Barclays Maintains Overweight on Universal Health Services, Lowers Price Target to $250
➖ NeutralBenzinga•Sep 18, 2025, 12:17 PM•Also:
Cantor Fitzgerald Reiterates Neutral on Universal Health Services, Maintains $227 Price Target
➖ NeutralBenzinga•Aug 26, 2025, 01:24 PM
RBC Capital Maintains Sector Perform on Universal Health Services, Raises Price Target to $206
📈 PositiveBenzinga•Aug 19, 2025, 01:46 PM
Hospital stocks fall as White House hints open to Medicare cuts
📉 NegativeSeeking Alpha•Jun 9, 2025, 05:12 PM•Also: , ,
Frequently Asked Questions about UHS
What is UHS's current stock price?
Universal Health Services, Inc. (UHS) is currently trading at $227.46 per share. The stock has moved +1.21% today.
What is the analyst price target for UHS?
The average analyst price target for UHS is $251.55, based on 1 analyst.
What sector is Universal Health Services, Inc. in?
Universal Health Services, Inc. operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the NYSE exchange.
What is UHS's market cap?
Universal Health Services, Inc. has a market capitalization of $14.67 billion, making it a large-cap company.
Does UHS pay dividends?
No, Universal Health Services, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACHC
Acadia Healthcare Company, Inc.
$14.41
Mkt Cap: $1.3B
ADUS
Addus HomeCare Corporation
$112.82
Mkt Cap: $2.1B
AMN
AMN Healthcare Services, Inc.
$16.04
Mkt Cap: $0.6B
CYH
Community Health Systems, Inc.
$3.26
Mkt Cap: $0.5B
DVA
DaVita Inc.
$115.20
Mkt Cap: $8.1B
EHC
Encompass Health Corporation
$106.39
Mkt Cap: $10.7B
ENSG
The Ensign Group, Inc.
$181.39
Mkt Cap: $10.4B
FMS
Fresenius Medical Care AG & Co. KGaA
$23.51
Mkt Cap: $13.8B
HCA
HCA Healthcare, Inc.
$472.98
Mkt Cap: $114.8B
LFST
LifeStance Health Group, Inc.
$7.05
Mkt Cap: $2.7B
Explore stocks similar to UHS for comparison